Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 4/2020

01-04-2020 | Mastectomy | Breast Oncology

Identifying Factors Predicting Long-Term Opioid Use After Mastectomy

Author: Sarah M. DeSnyder, MD

Published in: Annals of Surgical Oncology | Issue 4/2020

Login to get access

Excerpt

In the 1990s, a surge in opioid prescriptions occurred in response to the declaration by the Joint Commission on Accreditation of Healthcare Organizations that pain is the “fifth vital sign.” The resulting opioid epidemic has spurred efforts by health care providers, particularly surgeons, to decrease opioid prescribing while maintaining equivalent postoperative pain control. …
Literature
1.
2.
Lee JS, Hu HM, Edelman AL, et al. New persistent opioid use among patients with cancer after curative-intent surgery. J Clin Oncol. 2017;35:4042–9.CrossRef
3.
Park KU, Kyrish K, Terrell J, et al. Surgeon perception versus reality: opioid use after breast cancer surgery. J Surg Oncol. 2019;119; 909–15.CrossRef
4.
Overton HN, Hanna MN, Bruhn WE, et al. Opioid-prescribing guidelines for common surgical procedures: an expert panel consensus. J Am Coll Surg. 2018;227:411–8.CrossRef
5.
Scully RE, Schoenfeld AJ, Jiang W, et al. Defining optimal length of opioid pain medication prescription after common surgical procedures. JAMA Surg. 2018;153:37–43.CrossRef
6.
7.
8.
Temple-Oberle C, Shea-Budgell MA, Tan M, et al. Consensus review of optimal perioperative care in breast reconstruction: Enhanced Recovery After Surgery (ERAS) Society recommendations. Plast Reconstr Surg. 2017;139:1056e–1071e.CrossRef
9.
Lee JS, Howard RA, Klueh MP, et al. The impact of education and prescribing guidelines on opioid prescribing for breast and melanoma patients. Ann Surg Oncol. 2019;26:17–24.CrossRef
10.
Rojas KE, Manasseh DM, Flom PL, et al. A pilot study of breast surgery Enhanced Recovery After Surgery (ERAS) protocol to eliminate narcotic prescription at discharge. Breast Cancer Res Treat. 2018;171:621–6.CrossRef
Metadata
Title
Identifying Factors Predicting Long-Term Opioid Use After Mastectomy
Author
Sarah M. DeSnyder, MD
Publication date
01-04-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 4/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08233-y

Other articles of this Issue 4/2020

Annals of Surgical Oncology 4/2020 Go to the issue

Colorectal Cancer

Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort

Breast Oncology

Identifying Factors Predicting Prolonged Opioid Use After Mastectomy

ASO Author Reflections

ASO Author Reflections: Central Pancreatectomy Versus Distal Pancreatectomy and Pancreaticoduodenectomy for Benign or Low-Grade Malignant Neoplasms: A Propensity Score-Matched Study with Long-Term Functional Outcomes and Pancreas Volumetry

Peritoneal Surface Malignancy

Comment on “Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery”

Urologic Oncology

Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis

Hepatobiliary Tumors

Robotic ALPPS